Go Deep
Vineet Laboratories Limited
Vineet Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,758 | 37.9 | 1.60 | 0.99 | 37.93 |
Vineet Laboratories Limited Quarterly Results
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 188,914,000.0 | 156,483,000.0 | 174,195,000.0 | 74,418,000.0 |
| Net Profit | 7,251,000.0 | 8,507,000.0 | 4,010,000.0 | -8,661,000.0 |
| EPS | 0.4 | 0.9 | 0.4 | -0.8 |
Vineet Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 594,010,000.0 | 749,950,000.0 | 1,505,913,000.0 | 2,122,933,000.0 | — |
| Net Profit | 11,108,000.0 | -201,910,000.0 | 10,271,000.0 | 12,525,000.0 | — |
| EPS | — | -20.9 | 0.9 | 1.1 | 6.0 |
Vineet Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,247,834,000.0 | 945,401,000.0 | 1,168,719,000.0 | 1,158,492,000.0 | — |
| Total Liabilities | 791,814,000.0 | 798,925,000.0 | 821,477,000.0 | 821,658,000.0 | — |
| Total Equity | 456,020,000.0 | 146,476,000.0 | 347,242,000.0 | 336,834,000.0 | — |
Owes vs Owns
Vineet Laboratories Limited owed ₹0.63 for every ₹1 it owned in Mar 2026, down from ₹0.71 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.63× | 0.85× | 0.70× | 0.71× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Vineet Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 13.7%Receivables 9.1%Inventory 51.4%Fixed assets (tangible) 19.4%Long-term investments 0.8%Other assets 5.6%
How it's funded — Mar 2026
Short-term debt 28.1%Long-term debt 8.2%Payables 20.3%Other liabilities 6.8%Shareholders' equity 36.5%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 17.1 | 0.3 | 0.2 | 0.6 |
| Receivables | 11.4 | 13.2 | 31.6 | 35.2 |
| Inventory | 64.1 | 50.0 | 49.4 | 46.2 |
| Fixed assets (tangible) | 24.2 | 25.5 | 26.9 | 26.6 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 1.0 | 0.2 | 0.2 | 0.1 |
| Other assets | 7.0 | 5.4 | 8.5 | 7.1 |
| Liabilities & equity | ||||
| Short-term debt | 35.1 | 36.3 | 40.4 | 26.2 |
| Long-term debt | 10.2 | 3.8 | 3.9 | 4.8 |
| Payables | 25.3 | 33.6 | 32.3 | 34.9 |
| Other liabilities | 8.5 | 6.2 | 5.6 | 16.2 |
| Shareholders' equity | 45.6 | 14.6 | 34.7 | 33.7 |
| Net tangible assets | 45.6 | 14.6 | 34.7 | 33.7 |
Vineet Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -120,319,000.0 | 114,909,000.0 | -66,109,000.0 | -96,162,000.0 | — |
| Investing Activities | -11,100,000.0 | -31,819,000.0 | -22,218,000.0 | -66,856,000.0 | — |
| Financing Activities | 297,434,000.0 | -82,301,000.0 | 84,298,000.0 | 2,731,000.0 | — |